Keros Therapeutics, Inc. · NASDAQ:KROS
Keros Therapeutics, Inc. shareholders
As of Jun 30, 2026, 127 institutions reported holding Keros Therapeutics, Inc. Largest: Nantahala Capital Management, LLC, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Keros Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 2.82M | +1.46M | Aug 19, 2026 | |
| BlackRock | 2.79M | +382K | Aug 7, 2026 | |
| Vanguard | 1.63M | −31,031 | Aug 13, 2026 | |
| AQR Capital Management LLC | 968K | +561K | Aug 14, 2026 | |
| Orbimed Advisors LLC | 759K | no change | Aug 14, 2026 | |
| Federated Hermes, Inc. | 700K | +11,198 | Aug 12, 2026 | |
| Mackenzie | 628K | +476K | Aug 13, 2026 | |
| Madison Avenue Partners, LP | 627K | no change | Aug 14, 2026 | |
| Qube Research & Technologies Ltd | 609K | −116K | Aug 14, 2026 | |
| Jacobs Levy Equity Management, Inc | 605K | −101K | Aug 14, 2026 |